Overview

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the dermal sensitization potential of azelaic acid pre-foam formulation.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
LEO Pharma
Collaborator:
Bayer
Treatments:
Azelaic acid